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Abstract: The use of nanoparticles to enhance the effect of radiation-based cancer treatments is 
a growing field of study and recently, even nanoparticle-induced improvement of proton therapy 
performance has been investigated. Aiming at a clinical implementation of this approach, it 
is essential to characterize the mechanisms underlying the synergistic effects of nanoparticles 
combined with proton irradiation. In this study, we investigated the effect of platinum- and 
gadolinium-based nanoparticles on the nanoscale damage induced by a proton beam of thera-
peutically relevant energy (150 MeV) using plasmid DNA molecular probe. Two conditions of 
irradiation (0.44 and 3.6 keV/μm) were considered to mimic the beam properties at the entrance 
and at the end of the proton track. We demonstrate that the two metal-containing nanoparticles 
amplify, in particular, the induction of nanosize damages (2 nm) which are most lethal for 
cells. More importantly, this effect is even more pronounced at the end of the proton track. This 
work gives a new insight into the underlying mechanisms on the nanoscale and indicates that 
the addition of metal-based nanoparticles is a promising strategy not only to increase the cell 
killing action of fast protons, but also to improve tumor targeting.
Keywords: gadolinium-based nanoparticles, platinum nanoparticles, nanosensitization, 
theranostics
Introduction
In the last decade, important developments in nanomedicine have opened up new 
perspectives for tumor diagnostics and targeted cancer therapy.1 Different studies 
have demonstrated that nanoparticles (NPs) conjugated with specific ligands can effi-
ciently target malignant tumor cells.2–4 In addition, NPs composed of high-Z elements 
such as noble metals or lanthanides amplify the effect of radiation treatment.5 This 
phenomenon, which was first evidenced for platinum complexes combined with high-
energy photons6,7 and fast ions,8 was later demonstrated for gold NPs (AuNPs)9 and 
platinum NPs (PtNPs)10 in combination with photons or fast ions. Subsequent simula-
tion studies have led to first insights into this amplification effect.11–14 Furthermore, 
nanostructures were found to not only amplify radiation effects, but also improve in 
situ tumor diagnostics. In particular, gadolinium-based NPs (GdBNs) are magnetic 
resonance imaging active agents for which amplification of cell killing was observed 
using high-energy photons15–17 and carbon ions as incident radiation.18 The new prop-
erties of these multimodal compounds open up promising perspectives to implement 
theranostics (therapy and diagnosis based on a single compound) in radiation-based 
cancer therapy.
In parallel, the use of fast ions (protons and carbon ions) has proven to be another 
promising approach to treat cancer. Fast ions are predominantly used for treatment of 
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solid tumors embedded in sensitive tissues (eg, in the region 
of the head, neck, or other sensitive organs), for radioresistant 
tumors, and in case of pediatric patients.19 At present, numer-
ous proton therapy centers are under construction throughout 
the world. Compared to photons, the main advantage of ions 
stems from their unique dose–depth distribution, which peaks 
in a well-defined depth at the end of the particle tracks (Bragg 
peak), enabling superior dose deposition in the tumor. The 
tissues located in front of and behind the tumor, therefore, 
receive low doses. However, for clinical use, the ion beam 
needs to be energy modulated to implement a spread-out 
Bragg peak that ensures constant physical dose over the 
total tumor volume. Unfortunately, this energy modulation 
increases the dose deposition in tissues in front of the tumor. 
The addition of NPs in the tumor has been proposed as a 
new strategy to enhance selective cell killing in the tumor 
and, thus, overcome the limitation of hadron therapy. Few 
studies have demonstrated the efficiency of high-Z NPs to 
amplify the effects of fast protons. In particular, Kim et al20 
reported that cell survival decreases upon irradiation with 
45 MeV protons, when tumor cells are loaded with gold or 
iron NPs. Polf et al21 observed a similar decrease in prostate 
tumor cell survival when loaded with AuNPs and irradiated 
with 160 MeV protons. Recent in vivo studies performed with 
45 MeV protons demonstrated that the addition of metallic 
NPs results in a faster tumor remission in mice.22
Even though the beneficial effect of NPs on cell killing 
induced by fast proton radiation is established, the underly-
ing nanoscale mechanisms remain poorly understood. Some 
studies ascribed the enhancement of radiation effects by NPs 
as due to ion-induced release of electron bursts, subsequently 
leading to the production of reactive oxygen species (ROS) 
clusters in the medium.10 In contrast, Kim et al20 first attrib-
uted this effect to proton-induced X-ray emission. Despite 
the fact that this explanation was later dismissed, there is still 
an urgent need to better understand the nanoscale processes 
induced in the presence of NPs.
The present study aims at shedding light on the elemen-
tary mechanisms that govern the effects of nanoagents when 
combined with fast protons. It is commonly accepted that 
nanosize lesions, also called complex damages, are the most 
lethal for the cells.23 In this work, we quantified the efficacy 
of 3 nm platinum (Z=78) and 5 nm gadolinium (Z=64) based 
NPs to amplify nanosize lesions upon fast proton irradiation. 
The plasmid pBR322 was used as a molecular probe to quan-
tify simple and complex damages in biomolecules.24 Note 
that here pBR322 is not considered as a model for nuclear 
DNA. The experiments were performed with ion beams, 
which mimic the beam at the entrance of the ion track (linear 
energy transfer [LET] =0.44 keV/μm) and the beam at the 
end of the track (LET =3.6 keV/μm). We also characterized 
the influence of hydroxyl radicals on the NP effects.
Materials and methods
samples
The 4,361 base pair plasmid pBR322 (Euromedex, Souffel-
weyersheim, France) (molecular weight =2.83×106 Da) was 
diluted in a Tris-ethylenediaminetetraacetic acid (Tris-EDTA 
or TE) buffer solution (10 mM Tris-HCl [pH =7.6] and 1 
mmol/L EDTA) that mimics the medium conditions of living 
cells. Prior to irradiation, 95% of the plasmids were found to 
be supercoiled and 5% had circular conformation, indicative of 
a single-strand break (SSB). The linear conformation, which 
is indicative of double-strand breaks (DSBs), was absent. 
Here, DSB corresponds mainly to two face-to-face SSB 
lesions separated by ,10 base pairs. Hence, the production 
of DSB is used to probe the induction of nanosize molecular 
damage (also called complex damage). After irradiation, the 
three plasmid conformations were separated and quantified by 
agarose gel electrophoresis, as described elsewhere.10
PtNPs were synthesized by radiolysis, a unique and clean 
method. Synthesis takes place in water without addition of 
reducing agents. In the process, solvated electrons and reduc-
ing radicals (H•) reduce the metal precursors homogeneously, 
leading to metal NPs that are homogeneous in size.10 Briefly, 









(10−4 mol/L) (Sigma-Aldrich Co., St Louis, MO, USA) was 
used as the precursor and polyacrylic acid (10−2 mol/L) (Sigma-
Aldrich Co.) as the stabilizer. After deaeration, the solutions 
were irradiated by gamma rays provided by a panoramic Co60 
gamma source (LCP, Orsay, France). The platinum complex 
was reduced by solvated electrons and H• radicals stemming 
from radiolysis. Complete reduction of platinum (+II) in plati-
num (0) was obtained for a dose of 1,000 Gy. Homogeneous 
NPs of 3 nm diameter were produced.10 The PtNPs contain on 
an average 1,000 platinum atoms. Stored under dark conditions 
at 4°C, PtNPs are stable for several weeks. For the present 
experiments, PtNPs were diluted in ultrapure water to obtain 
a final platinum concentration of 4.23×10−5 mol/L.
GdBNs were synthesized as described elsewhere.25 The 
nanoparticles are composed of a polysiloxane core sur-
rounded by gadolinium chelates. GdBNs are functionalized 
with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic 
acid. Each NP contains approximately ten gadolinium 
atoms and has a diameter of ~3 nm. Stored under dark 
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Improving proton therapy by metal-containing nanoparticles
For the present experiments, GdBNs were diluted with 
ultrapure water to obtain a final gadolinium concentration 
of 4.23×10−5 mol/L.
Some experiments were performed in the presence of 
dimethyl sulfoxide (DMSO) 1 mol/L,
 
an efficient hydroxyl 
radical scavenger.26
Proton beam irradiation
The 150 MeV proton beam was provided by the AGOR 
cyclotron located at the Kernfysisch Versneller Instituut – 
Center for Advanced Radiation Technology in Groningen 
(the Netherlands). The beam was scattered using a double-
scatter foil setup to produce a homogeneous irradiation field 
with a variation of ,3% over 70 mm field diameter. 
For irradiation, the samples were placed in a water 
 container at a depth of 30 mm measured along the beam 
(Figure 1). This geometry was used to avoid material density 
changes in the sample region and prevent dosimetry artifacts. 
The location of the samples along the dose–depth curve was 
controlled with a precision of ~1 mm, so that the dose devia-
tion was ,3% over a diameter of 3.5 cm.
The averaged LET at each position was calculated 
using Geant 4 simulations (version 4.10.00.p01, with the 
QGSP_BERT model for hadronic reactions and the standard 
electromagnetic interaction model with option 3).27 We found 
0.44 keV/μm at the entrance channel and 3.6 keV/μm at the 
Bragg peak.
The dose delivered to the samples was determined by 
recording the signal from an ionization chamber that served 
as an online beam monitor during sample irradiation. For 
calibration of the ionization chamber to an absolute dose 
rate, a calibrated Markus chamber was used (PTW Freiburg 
GmbH, Freiburg, Germany). During the calibration proce-
dure, the samples were removed and the Markus chamber 
was positioned at the sample position. This procedure is 
proposed in the respective protocol of the International 
Atomic Energy Agency.28
Four sets of experiments were performed with samples 
containing 1) metal-free plasmid samples used as controls, 
2) plasmids and PtNPs, 3) plasmids and GdBNs, and 
4) plasmids and DMSO (with or without NPs). These experi-
ments were performed under atmospheric conditions at room 
temperature with doses ranging from 0 to 350 Gy for most of 
the experiments and up to 800 Gy in the presence of DMSO. 
The dose rate was close to 30 Gy/min.
analysis
The samples were analyzed by agarose gel electrophoresis as 
detailed elsewhere.10,29 After migration at room temperature, 
the gel was stained with ethidium bromide and exposed to 
ultraviolet light (312 nm). The plasmid fluorescence was 
recorded with a charged coupled device camera. The den-
sitometry was performed using the Quantity One software 
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The yields of SSBs and DSBs were determined as described 
elsewhere.10,29 Briefly, considering that ethidium bromide 
binds 1.47 times less efficient to supercoiled plasmids (S) 
than in relaxed (R) and linear (L) forms, we calculated the 















No significant artifact due to the binding of 
NPs to plasmids was found.
Results
Influence of PtNPs
The results obtained at 0.44 and 3.6 keV/μm are presented in 
Figure 2. The curves exhibit linear dose dependences, which 
are indicative of a single hit mechanism.29 For both LETs, 
the addition of PtNPs significantly increased the number of 
SSBs and DSBs.




), defined as the 
number of breaks per Dalton and per Gray, are determined 
using the slopes of the curves.10,29 The results are reported 




 increased in the 
presence of PtNPs. This result demonstrates the properties of 
PtNPs to amplify the proton radiation effects. This is similar to 
our previous observation made after carbon ions treatment.10

















The AF for DSBs (AF
DSB
) was significantly higher than 
for SSBs (AF
SSB
). This shows that PtNPs are particularly 
efficient in increasing the production of nanosize lesions, 
which are most difficult to repair in living cells. This result 
confirms the results obtained with fast carbon ions used as 
ionizing radiation.10,29
Note that the number of tracks leading to a given depos-
ited dose is eight times lower at high LET (3.6 keV/μm) 
than at low LET (0.44 keV/μm), which diminishes the geo-
metrical cross section (probability for the ion and its track 
to activate an NP). This explains the decrease of SSB and 






 was used to characterize the damage qual-
ity related to the radiation exposure. For instance, a decrease 
of this ratio implies a relative increase in DSB production 
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Figure 2 ssBs (A) and DsBs (B) induced in DNa plasmids in the presence of PtNPs (red) and in the control (black) irradiated by protons at the ec and at the BP.
Abbreviations: BP, Bragg peak; DsB, double-strand break; ec, entrance channel; PtNP, platinum nanoparticle; ssB, single-strand break.
Table 1 ssB and DsB yields (mssB, mDsB) induced by protons (0.44 and 3.6 keV/μm) in the control and in plasmids with PtNPs





1010× − mDSB 1110× −
0.44 keV/μm control 36 (±1) 2.2 (±0.1) – – 163 (±13)
Plasmids + PtNP 49.8 (±0.7) 3.5 (±0.1) 1.38 (±0.07) 1.6 (±0.1) 142 (±6)
3.6 keV/μm control 24.4 (±0.7) 1.62 (±0.07) – – 152 (±15)






 ratio and the amplification factors are reported.
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Improving proton therapy by metal-containing nanoparticles
and indicates an increase in lethality, and we observed such 
a decrease with increase in the ion beam LET. This confirms 
the increase of complex damage at the end of the track when 






pronounced in the presence of PtNPs. Accordingly, the pres-
ence of PtNPs not only increases the number of lesions, but also 
their size and lethality. This effect is even more pronounced 
at the end of the ion track, which demonstrates the unique 
properties of PtNPs to improve proton radiation performance 
by increasing lethality and volume targeting.
effect of gdBNs
The effect of GdBNPs was studied under similar conditions 
as used for PtNPs. The comparison of GdBNs and PtNPs is 
illustrated in Figure 3 for proton irradiation at 0.44 keV/μm 











and AFs obtained at the two LETs (0.44 and 3.6 keV/μm) 
are summarized in Table 2.
As shown in Figure 3, addition of GdBNs amplifies the 
induction of molecular damages, as observed with PtNPs. 
However, for the same metal concentration, GdBNs are 










(PtNP) =1.9 at 3.6 keV/μm).
As observed with PtNPs, the induction of complex dam-
ages is more pronounced at the end of the track (AF =1.19 
at 0.44 keV/μm and 1.32 at 3.6 keV/μm).
role of water radicals
In previous studies, we highlighted the major role of ROS in 
the effect of NPs to amplify radiation-induced damages.10,18 
In this study, we performed similar experiments with DMSO, 
a commonly used radical scavenger (see “Materials and 
methods” section). In Figure 4 is presented the induction of 
DSBs induced in the presence of PtNPs with and without 
DMSO at the two LETs under study. A summary of the SSB 
and DSB yields and related data obtained with PtNPs and 
GdBNs is presented in Table 3.
For both LETs, the number of molecular breaks (SSBs 
and DSBs) in samples containing PtNPs and GdBNs 
decreased dramatically in the presence of DMSO (graphs 
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Figure 3 ssBs (A) and DsBs (B) induced by protons at the entrance channel (0.44 keV/μm) in plasmids in the presence of PtNPs () or gdBNs () and in the control ().
Abbreviations: DsB, double-strand break; gdBN, gadolinium-based nanoparticle; PtNP, platinum-based nanoparticle; ssB, single-strand break.
Table 2 ssB and DsB yields (mssB, mDsB) induced by protons at 0.44 and 3.6 keV/μm in the control (pure plasmids) and in plasmids in 
the presence of gdBNs 





1010× − mDSB 1110× −
0.44 keV/μm control 36 (±1) 2.2 (±0.1) – – 163 (±13)
Plasmids + gdBN 42.8 (±0.7) 2.65 (±0.07) 1.18 (±0.03) 1.19 (±0.06) 162 (±6)
3.6 keV/μm control 24.4 (±0.7) 1.62 (±0.07) – – 152 (±15)






 ratio and aFs are reported.
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The contribution of ROS (HO• radicals and by-products) 
can be quantified as the following ratio (given here for the 
















for PtNPs and GdBNs 
were extracted from Tables 1 and 2, respectively. The cal-
culated values are reported in the right columns of Table 3. 
The contributions of hydroxyl radicals are higher than 90% 
for PtNPs and GdBNs, which shows that the production of 
HO• radicals is a key step in the amplification of radiation 
effects by the NPs. This finding is similar to our previous 
results with carbon ions and photons used as ionizing 
radiations.18,30 It is also in agreement with a recent study 
which evidenced the presence of HO• radicals in the case of 
AuNPs activated by high-energy photons.31,32 In this context, 
it is important to note that the dose rate used in our work 
(30 Gy/min) is higher than the dose rates commonly used in 
therapy (typically 3–7 Gy/min). However, even at 30 Gy/min, 
effects such as hydroxyl radical recombination are still low 
and oxidative stress processes most likely remain unaffected 
(as opposed to, eg, flash irradiation).
Discussion
The early-stage processes involved in the amplification of 
proton radiation effects by metallic NPs have been detailed 
elsewhere.10,18 Briefly, incident ions and secondary electrons 
produced along the particle track activate NPs by means 
of Coulombic interaction. The excitation and ionization 
probability increases with the atomic number of the target. 
It is higher for platinum (Z
Pt




As shown recently, the excitation of collective electronic 
modes such as plasmons may also contribute to the activa-
tion of metal core NPs (ie, PtNPs) by 1 MeV protons or 
below.13 This effect is expected to be strongly dependent on 
proton velocity. At the end of the track (in the Bragg peak), 
where proton velocities are of the order of the velocities of 
molecular valence electrons, plasmon excitation in metals 
$



































Figure 4 DsBs induced by protons at 0.44 keV/μm (A) and 3.6 keV/μm (B) in samples in the presence of PtNPs (), PtNPs with DMsO (Δ), in the control (), and in the 
control with DMsO ().
Abbreviations: DMsO, dimethyl sulfoxide; DsB, double-strand break; PtNP, platinum nanoparticle; ssB, single-strand break.
Table 3 ssB and DsB yields (mssB, mDsB) induced by protons at 0.44 and 3.6 keV/μm in the control (pure plasmids) and in plasmids with 
PtNPs or gdBNs in the presence of DMsO
Beam LET Sample Yields (breaks per Da per Gy) ROS contribution (%)
mSSB
1010× − mDSB 1110× − SSB DSB
0.44 keV/μm control + DMsO 0.97 (±0.03) 0.15 (±0.01) 97 93
Plasmids + PtNP + DMsO 1.72 (±0.03) 0.16 (±0.01) 96 95
Plasmids + gdBN + DMsO 0.88 (±0.04) 0.141 (±0.005) 98 95
3.6 keV/μm control + DMsO 1.12 (±0.02) 0.219 (±0.003) 95 87
Plasmids + PtNP + DMsO 3.05 (±0.08) 0.25 (±0.02) 91 92
Plasmids + gdBN + DMsO 0.86 (±0.02) 0.17 (±0.02) 96 92
Note: The contributions of hydroxyl radicals for ssBs and DsBs are reported in the right columns.
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Improving proton therapy by metal-containing nanoparticles
The effect is more pronounced in the region of the 
Bragg peak than in the entrance region of the tracks, which 
increases the therapeutic potential of these NPs even more. 
In particular, we established that the presence of NPs 
enhances the yield of complex nanosize molecular damages 
(2 nm), which is known to be most lethal for cells. The 
formation of these damages can be attributed to production 
of radical clusters resulting from NP activation. The fact 
that stronger radiation damage amplification was found for 
Pt-based NPs (AF =1.93) than for Gd-based NPs (AF =1.33) 
can only partly be explained by the differences in atomic 
number Z. It is very likely that collective electronic exci-
tations (plasmons) play an important role in high-energy 
proton–NP interactions (as recently predicted theoretically) 
and are responsible for the superior efficiency of PtNPs. The 
present study thus confirms the potential of high-Z metal-
containing NPs to increase the efficiency of high-energy 
proton radiation action, particularly in the tumor volume at 
the end of the track. Accordingly, combining proton therapy 
with administration of PtNPs or GdNPs could be a promis-
ing strategy for improving proton therapy. Furthermore, 
the combination of platinum and gadolinium could open 
theranostic perspectives in proton therapy.
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can be an important energy deposition channel. At the track 
entrance, where proton energies are much higher, interactions 
with single electrons of the medium are expected to dominate 
(Bethe–Bloch regime).
After the activation step, the electronic de-excitation of 
NP leads to the emission of electron bursts into the surround-
ing medium. The de-excitation of collective modes is even 
higher for atoms rich in 5d electrons (ie, platinum).14
The interaction of these emitted electrons with water 
molecules in the medium leads to the production of free 
radicals (HO• as precursor and by-products) concentrated 
in clusters around the NPs. We, thus, attribute the induction 
of nanosize molecular damages to the interaction of radical 
clusters with the plasmid DNA. Note that these nanoscale 
processes depend exclusively on the electronic properties 
of NPs and may thus impact all biological targets, including 
nucleic acids, proteins, and lipids.
As shown before, the amplification of damages by NPs 
is remarkably stronger at the end of the particle track. For 
a better representation of this effect, we normalized the 
damage yield from a per-Gray to a per-track reference. As 
mentioned before, for a given dose deposition, the number 
of tracks is eight times lower at high LET (3.6 keV/μm) than 
at low LET (0.44 keV/μm). Thus, the relative production of 






















For the control, this ratio amounts to 5.8 (±0.4), which 
confirms that the production of DSBs increases with the dose 
deposition along the track (Figure 5). Interestingly, this ratio 
increases to 6.5 with GdBNs, and even more (7.2) with PtNPs 
(Figure 5). To our knowledge, this increase of the NP effect 
with the penetration depth of the incident ion is observed here 
for the first time. This finding supports the strategy to use 
NPs to improve not only the quality of the radiation treatment 
but also the localization of the effect at the end of the track, 
which is the major goal of proton therapy.
Conclusion
Using plasmid DNA as molecular probes, for the first time, 
we presented evidence that the presence of small (~3 nm) 
platinum- or GdBNs augments the radiation effects of fast 
protons. By quantification of molecular damage, we dem-
onstrated that this amplification effect is due to nanoscale 
processes that induce severe damage in biomolecules. These 
early-stage mechanisms are very likely characteristic for 
high-Z NPs in general, such as AuNPs activated by protons, 
and may explain the amplification of proton action observed 





























Figure 5 Amplification factor of nanosize molecular damage induced along a 
150 MeV proton track in the presence of metal-containing nanoparticles.
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